EUVIMEDAtrasti EUVIMED
Crossref

Combined pituitary function-test with four hypothalamic releasing hormones

J Schopohl, M Losa, A König, O A Müller, G K Stalla, K von Werder

Klinische Wochenschrift · 1986-04 · 64 (7) · 314-318

DOI: 10.1007/bf01711949 ↗

At a glance

Journal article in Klinische Wochenschrift, 1986-04. Written by J Schopohl and 5 co-authors. Major MEDLINE topics: Corticotropin-Releasing Hormone, Growth Hormone-Releasing Hormone, Pituitary Hormone-Releasing Hormones, Thyrotropin-Releasing Hormone. Cited 17 times so far (Crossref); 21 references.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Anterior pituitary function was investigated in ten healthy subjects by administering a combination of 200 micrograms thyrotropin releasing hormone (TRH), 100 micrograms gonadotropin releasing hormone (GnRH), 100 micrograms growth hormone releasing factor (GRF1-44), and 100 micrograms human corticotropin releasing factor (CRF). The same test protocol was performed in all subjects after pretreatment with 0.25 mg terguride. Five subjects were tested only with TRH and GnRH, five only with CRF, and six only with GRF. There was a prompt increase in all hormones after the administration of the four releasing hormones (RH). Pretreatment with terguride lowered the prolactin (PRL) increase (p less than 0.01) as well as the thyrotropin (TSH) peak (p less than 0.05) compared with the test without dopamine agonist pretreatment. The PRL levels after combined RH administration were significantly higher than after TRH and GnRH alone. Although four of the five subjects had higher TSH levels after combined RH administration than after TRH and GnRH alone, the difference was not significant. Other hormones were not significantly influenced by the combined RH administration or dopamine agonist pretreatment. Despite the fact that the interaction of the different releasing hormones and dopamine agonists influences the pituitary hormone response, combined RH administration seems to be a useful test for evaluating pituitary function also in patients receiving dopamine agonist therapy.

Subjects

MeSH terms (MEDLINE)

Corticotropin-Releasing HormoneGrowth Hormone-Releasing HormonePituitary Hormone-Releasing HormonesThyrotropin-Releasing HormoneAdrenocorticotropic HormoneAdultFemaleFollicle Stimulating HormoneGrowth HormoneHumansHydrocortisoneLisurideLuteinizing HormoneMalePituitary Function TestsPituitary Gland, AnteriorPremedicationProlactinRadioimmunoassayThyrotropin

Substances

Pituitary Hormone-Releasing HormonesdironylThyrotropin-Releasing HormoneAdrenocorticotropic HormoneProlactinLuteinizing HormoneFollicle Stimulating HormoneThyrotropinGrowth HormoneCorticotropin-Releasing Hormone

Cite

APA

Schopohl, J., Losa, M., König, A., Müller, O. A., Stalla, G. K., & von Werder, K. (1986). Combined pituitary function-test with four hypothalamic releasing hormones. Klinische Wochenschrift, 64(7), 314-318. https://doi.org/10.1007/bf01711949

Vancouver

Schopohl J, Losa M, König A, Müller OA, Stalla GK, von Werder K. Combined pituitary function-test with four hypothalamic releasing hormones. Klinische Wochenschrift. 1986;64(7):314-318. doi:10.1007/bf01711949

BibTeX
@article{Schopohl1986,
  author = {Schopohl, J and Losa, M and König, A and Müller, O A and Stalla, G K and von Werder, K},
  title = {Combined pituitary function-test with four hypothalamic releasing hormones},
  journal = {Klinische Wochenschrift},
  year = {1986},
  volume = {64},
  number = {7},
  pages = {314--318},
  doi = {10.1007/bf01711949}
}
Start for free →